DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Celsion Corporation (CLSN)
« Back to company indexCLSN Chatter Timeline
Stock Ticker for CLSN
Most Active Tweeters for CLSN
No tweets foundRecent Tweets for CLSN
 |
@WatchlistN Analyzing Celsion $CLSN and Achaogen $AKAO https://t.co/eGF3M7Lt62 August 21st 2018, 8:08pm |
 |
@Markfor65836606 $CLSN I am frustrated by this delay in Gen 1 as well but at this point it’s old news. Market gave a modest haircut and OM reiterated at $9. August 21st 2018, 6:08pm |
 |
@top10stocksof21 Celsion Corp. $CLSN Stock Live Analysis 03-15-2017 #nasdaq https://t.co/HuLo23rXqv August 21st 2018, 11:08am |
 |
@ZolmaxNews Celsion $CLSN Downgraded to Sell at Zacks Investment Research https://t.co/IwJmv0e65j August 21st 2018, 9:08am |
 |
@TranscriptDaily Equities Analysts Set Expectations for Celsion Co.’s Q3 2018 Earnings $CLSN https://t.co/ZhY8fcBo6D August 21st 2018, 5:08am |
 |
@bigbluecup721 Celsion Corp. $CLSN Stock Live Analysis 10-12-2017 #stockmarket https://t.co/LR6EqcmJIX August 20th 2018, 10:08pm |
 |
@ConsumerFeed Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/TdS4grFpvt August 20th 2018, 7:08pm |
 |
@registrarjourn Celsion $CLSN Receiving Somewhat Favorable Press Coverage, Accern Reports https://t.co/I1iuYx5Wmb August 20th 2018, 7:08pm |
 |
@EnterpriseLeade Celsion $CLSN Receiving Somewhat Favorable Press Coverage, Accern Reports https://t.co/xBnPgmWY9o August 20th 2018, 7:08pm |
 |
@MareaInformativ Celsion Co. $CLSN Expected to Earn Q3 2018 Earnings of -$0.42 Per Share https://t.co/xkueNwc65N August 20th 2018, 6:08am |
 |
@AmericanBanking Celsion Co. $CLSN Expected to Earn Q3 2018 Earnings of -$0.42 Per Share https://t.co/RAtlgBKm8o #stocks August 20th 2018, 1:08am |
|
@ConsumerFeed Celsion Co. $CLSN Expected to Earn Q3 2018 Earnings of -$0.42 Per Share https://t.co/wkGN1xR4A9 August 20th 2018, 1:08am |
 |
@ChartMill $CLSN shows a strong growth in EPS: 78.11%. https://t.co/57G7442c3v https://t.co/DnSgReCkxm August 19th 2018, 1:08pm |
|
@TranscriptDaily Celsion Co. $CLSN Expected to Post FY2022 Earnings of $1.40 Per Share https://t.co/1DBe7HKWho August 18th 2018, 3:08am |
|
@registrarjourn Analysts Offer Predictions for Celsion Co.’s FY2022 Earnings $CLSN https://t.co/f1GsTWYBED August 17th 2018, 6:08am |
|
@EnterpriseLeade Analysts Offer Predictions for Celsion Co.’s FY2022 Earnings $CLSN https://t.co/cz3EwBCvcN August 17th 2018, 6:08am |
 |
@OlympiaReport Celsion $CLSN Shares Down 9.4% on Disappointing Earnings https://t.co/VIxWrd0MVF August 16th 2018, 5:08pm |
 |
@WeekHerald Celsion $CLSN Shares Down 9.4% Following Weak Earnings https://t.co/TZyJCzw0uC August 16th 2018, 5:08pm |
 |
@dispatchtribune Celsion $CLSN Stock Price Down 9.4% Following Weak Earnings https://t.co/BacnpwZZDb August 16th 2018, 5:08pm |
|
@ZolmaxNews Celsion $CLSN Posts Quarterly Earnings Results, Misses Expectations By $0.19 EPS https://t.co/XyF8wSQcVM August 16th 2018, 5:08pm |
 |
@dailypoliticaln Celsion $CLSN Announces Earnings Results https://t.co/U5EePkG5Gh August 16th 2018, 5:08pm |
 |
@filing_scanner $CLSN New Insider Filing On: Fritz Frederick J. Transaction Code: P https://t.co/JDVgwKiXbr August 16th 2018, 4:08pm |
 |
@TickerReport Oppenheimer Weighs in on Celsion Co.’s FY2022 Earnings $CLSN https://t.co/frzg6QgKaV August 16th 2018, 9:08am |
|
@AmericanBanking Oppenheimer Weighs in on Celsion Co.’s FY2022 Earnings $CLSN https://t.co/Bx4LLP7TUu #stocks August 16th 2018, 9:08am |
|
@WatchlistN Oppenheimer Weighs in on Celsion Co.’s FY2022 Earnings $CLSN https://t.co/Blov9t8fDz August 16th 2018, 9:08am |
 |
@RatingsNetwork Oppenheimer Sets Celsion FY2022 Earnings Estimates at $1.40 EPS. https://t.co/cb9ZnQ0Y0l $CLSN #CLSN August 16th 2018, 9:08am |
 |
@InsiderAlertsIA $CLSN: New Insider Filing on Director FREDERICK J. FRITZ: https://t.co/510o1g4urw August 15th 2018, 2:08pm |
 |
@Allstocknews $CLSN New Form 4 for Celsion Corporation From our Stock News Alerts App August 15th 2018, 2:08pm |
 |
@StockTexts $CLSN Celsion Corporation SEC Filing: Form 4 https://t.co/j6L0xh7tSk August 15th 2018, 2:08pm |
 |
@bret_jensen $CLSN $MOTS 2 Notable morning analyst calls amid the market sell-off early today...https://t.co/ccLW4pgd2T August 15th 2018, 11:08am |
 |
@SolarMelt $CLSN Bottom-Line: The mounting evidence clearly suggests that the combination of Thermodox plus either optimized R… https://t.co/f3sX773okC August 14th 2018, 11:08pm |
|
@SolarMelt $CLSN Oxford University also tested Thermodox recently, but with focused ultrasound instead of RFA - less invasive.… https://t.co/4AELcRunnb August 14th 2018, 11:08pm |
|
@SolarMelt $CLSN The NIH recently conducted a post hoc analysis on the HEAT data. Focusing on 437 single lesion patients, the… https://t.co/4ZY8zEdDJE August 14th 2018, 11:08pm |
|
@SolarMelt $CLSN A recent Interim Analysis combining 411 patients from both arms of OPTIMA (RFA with and without ThermoDox) re… https://t.co/9cRJq5IqmN August 14th 2018, 11:08pm |
|
@SolarMelt $CLSN ThermoDox (HCC) OPTIMA - P3 Interim Efficacy Analysis - Late 2Q19 In the prior P3 (HEAT) trial, a median OS w… https://t.co/bw5wc0Untc August 14th 2018, 11:08pm |
|
@SolarMelt $CLSN Update GEN-1 (Ovarian Cancer) OVATION-I - P1b - Final PFS Data in 2H18 OVATION-II - P1/2 - Multiple Updates 4… https://t.co/Mw4c4kZoV3 August 14th 2018, 11:08pm |
|
@Markfor65836606 $CLSN delay is incompetence and an indictment of management team. They have no idea what will happen with Gen1 or Thermodox. August 14th 2018, 10:08pm |
|
@MareaInformativ Celsion $CLSN Stock Price Down 9.4% https://t.co/GRF9plg6Ox August 14th 2018, 9:08pm |
 |
@bbnsnews Celsion $CLSN Shares Down 9.4% https://t.co/z9R5vgUe6x August 14th 2018, 9:08pm |
|
@MareaInformativ Celsion $CLSN Releases Earnings Results, Misses Expectations By $0.18 EPS https://t.co/qMRX4y6FL9 August 14th 2018, 12:08pm |
|
@dakotafinancial Celsion $CLSN Releases Quarterly Earnings Results, Misses Expectations By $0.18 EPS https://t.co/YPpaD4AWe1 August 14th 2018, 11:08am |
|
@AmericanBanking Celsion $CLSN Announces Earnings Results https://t.co/SsVVCAdUuW #stocks August 14th 2018, 11:08am |
|
@ConsumerFeed Celsion $CLSN Posts Quarterly Earnings Results, Misses Expectations By $0.18 EPS https://t.co/CCqDhQd8i2 August 14th 2018, 11:08am |
 |
@earningscast $CLSN Listen to Q2 2018 Celsion Corporat Earnings Call (EPS -0.46 vs EST -0.27) live at 11:00 AM,ondemand after https://t.co/D0XDsNlihZ August 14th 2018, 10:08am |
 |
@investornetwork #InvestorEvent $CLSN to host Q2 Earnings Call TODAY at 11am Eastern! Stream LIVE or on Replay at https://t.co/09tBdcsM6p August 14th 2018, 10:08am |
 |
@StockNewsNow $CLSN Celsion Corporation Reports Second Quarter 2018 Financial Results and Provides Business Update https://t.co/MwsVAZlT8P August 14th 2018, 10:08am |
|
@Allstocknews $CLSN New Form 10-Q for Celsion Corporation From our Stock News Alerts App August 14th 2018, 9:08am |
|
@StockTexts $CLSN Celsion Corporation SEC Filing: Form 10-Q https://t.co/hWtjetCbEw August 14th 2018, 9:08am |
 |
@Stock_News_Now $CLSN: New SEC Filing for CLSN: Form 8-K (No. 0001493152-18-011626): https://t.co/UFyfNwWAF4 August 14th 2018, 9:08am |
 |
@sep_sal RT @MarketCurrents: Celsion net loss widens in Q2 https://t.co/WoJNqjwCxt #premarket $CLSN August 14th 2018, 9:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.